Involvement of heparan sulfate proteoglycans in cellular uptake of high molecular weight kininogen

Biological Chemistry

Volumn 390, Issue 2, 2009, Pages 145-155

  Melo, Katia R B ^a   Gutierrez, Augusto ^a   Nascimento, Fabio D ^a   Araújo, Mariana Kátia Fábio S ^a   Sampaio, Misako U ^a   Carmona, Adriana K ^a   Coulson Thomas, Yvette M ^a   Trindade, Edvaldo S ^a,b   Nader, Helena B ^a   Tersariol, Ivarne L S ^a,c   Motta, Guacyara ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDADE TECNOLÓGICA FEDERAL DO PARANÁ   (Brazil)

^c UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

Endocytosis; Endothelial cells; Glycosaminoglycans; Kinin release; Proteolysis; Tumor cells

Indexed keywords

BETA CYCLODEXTRIN; BIOTIN; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; CHLOROQUINE; DEOXYGLUCOSE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HIGH MOLECULAR WEIGHT KININOGEN; METHYL BETA CYCLODEXTRIN; PROTEOGLYCAN; PROTEOHEPARAN SULFATE;

AORTA; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; ENERGY; HYPOTHESIS; INTERNALIZATION; LOW TEMPERATURE; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RABBIT; TUMOR CELL;

ANIMALS; AORTA; CELL LINE; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; ENDOCYTOSIS; ENDOTHELIAL CELLS; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNOHISTOCHEMISTRY; KININOGEN, HIGH-MOLECULAR-WEIGHT; PROTEOGLYCANS; RABBITS;

ALEXA; ORYCTOLAGUS CUNICULUS;

EID: 59949084806     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.016     Document Type: Article

References (53)

1. Anderson, R.G., Falck, J.R., Goldstein, J.L., and Brown, M.S. (1984). Visualization of acidic organelles in intact cells by electron microscopy. Proc. Natl. Acad. Sci. USA 81, 4838-4842.
2. Barros, N.M., Tersariol, I.L., Oliva, M.L., Araüjo, M.S., Sampaio, C.A., Juliano, L., and da Motta, G. (2004). Plasma prekallikrein/kallikrein processing by lysosomal cysteine proteases. Biol. Chem. 385, 551-555.
3. Belting, M. (2003). Heparan sulfate proteoglycan as a plasma membrane carrier. Trends Biochem. Sci. 28, 145-151.
4. Buonassisi, V. and Venter, J.C. (1976). Hormone and neurotransmitter receptors in an established vascular endothelial cell line. Proc. Natl. Acad. Sci. USA 73, 1612-1616.
5. Castillo, C.J., Colburn, P., and Buonassisi, V. (1987). Characterization and N-terminal sequence of a heparan sulphate proteoglycan synthesized by endothelial cells in culture. Biochem. J. 247, 687-693.
6. Cavallo-Medved, D., Mai, J., Dosescu, J., Sameni, M., and Sloane, B.F. (2005). Caveolin-1 mediates the expression and localization of cathepsin B, pro-urokinase plasminogen activator and their cell-surface receptors in human colorectal carcinoma cells. J. Cell Sci. 118, 1493-1503.
7. Cheng, G., Polito, C.C., Haines, J.K., Shafizadeh, S.F., Fiorini, R.N., Zhou, X., Schmidt, M.G., and Chavin, K.D. (2003). Decrease of intracellular ATP content downregulated UCP2 expression in mouse hepatocytes. Biochem. Biophys. Res. Commun. 308, 573-580.
8. Colman, R.W. (2006). Regulation of angiogenesis by the kallikrein-kinin system. Curr. Pharm. Des. 12, 2599-2607.
9. Colman, R.W. and Schmaier, A.H. (1997). Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90, 3819-3843.
10. Dedio, J., Wiemer, G., Rütten, H., Dendorfer, A., Schölkens, B.A., Müller-Esterl, W., and Wohlfart, P. (2001). Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins. Biol. Chem. 382, 1483-1490.
11. Desmazes, C., Gauthier, F., and Lalmanach, G. (2001). Cathepsin L, but not cathepsin B, is a potential kininogenase. Biol. Chem. 382, 811-815.
12. Esko, J.D., Stewart, T.E., and Taylor, W.H. (1985) Animal cell mutants defective in glycosaminoglycan biosynthesis. Proc. Natl. Acad. Sci. USA 82, 3197-3201.
13. Foerg, C., Ziegler, U., Fernandez-Carneado, J., Giralt, E., Rennert, R., Beck-Sickinger, A.G., and Merkle, H.P. (2005). Decoding the entry of two novel cell-penetrating peptides in HeLa cells: lipid raft-mediated endocytosis and endosomal escape. Biochemistry 44, 72-81.
14. Gozzo, A.J., Nunes, V.A., Carmoma, A.K., Nader, H.B., Dietrich, C.P., Silveira, V.L.F., Shimamoto, K., Ura, N., Sampaio, M.U., Sampaio, C.A.M., and Araüjo, M.S. (2002). Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int. Immunopharmacol. 2, 1861-1865.
15. Guo, Y.L. and Colman, R.W. (2005). Two faces of high-molecular-weight kininogen (HK) in angiogenesis: BK turns it on and cleaved HK (HKa) turns it off. J. Thromb. Haemost. 3, 670-676.
16. Hasan, A.A.K., Cines, D.B., Zhang J., and Schmaier, A.H. (1994). The carboxyl terminus of bradykinin and amino terminus of the light chain of kininogens comprise an endothelial cell binding domain. J. Biol. Chem. 269, 31822-31830.
17. Hasan, A.A.K., Cines, D.B., Ngaiza, J.R., Jaffe, E.A., and Schmaier, A.H. (1995). High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium. Blood 85, 3134-3143.
18. Higashiyama, S., Ishiguro, H., Ohkubo, I., Fujimoto, S., Matsuda, T., and Sasaki, M. (1986). Kinin release from kininogens by calpains. Life Sci. 39, 1639-1644.
19. Jo, M., Thomas, K.S., Marozkina, N., Amin, T.J., Silva, C.M., Parsons, S.J., and Gonias, S.L. (2005). Dynamic assembly of the urokinase-type plasminogen activator signaling receptor complex determines the mitogenic activity of urokinase-type plasminogen activator. J. Biol. Chem. 280, 17449-17457.
20. Joseph, K., Ghebrehiwet, B., Peerschke, E.I.B., Reid, K.B.M., and Kaplan, A.P. (1996). Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular 'heads' of C1q (gC1q-R). Proc. Natl. Acad. Sci. USA 93, 8552-8557.
21. Kirkpatrick, C.A. and Selleck, S.B. (2007). Heparan sulfate proteoglycans at a glance. J. Cell Sci. 120, 1829-1832.
22. Kozik, A., Moore, R.B., Potempa, J., Imamura, T., Rapala-Kozik, M., and Travis, J. (1998). A novel mechanism for BK production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens. J. Biol. Chem. 273, 33224-33229.
23. Kudo, T., Wei, E.Q., and Inoki, R. (1989). Activation of calcium ion-dependent proteinases by BK in dental pulp of the rat. Adv. Exp. Med. Biol. 247B, 627-631.
24. Lamb, M.E., Zhang, C., Shea, T., Kyle, D.J., and Leeb-Lundberg, L.M. (2002). Human B1 and B2 BK receptors and their agonists target caveolae-related lipid rafts to different degrees in HEK293 cells. Biochemistry 41, 14340-14347.
25. Lecaille, F., Kaleta, J., and Bromme, D. (2002). Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem. Rev. 102, 4459-4488.
26. Letoha, T., Gaal, S., Somlai, C., Czajlik, A., Perczel, A., and Penke, B. (2003). Membrane translocation of penetratin and its derivatives in different cell lines. J. Mol. Recognit. 16, 272-279.
27. Lim, B.L., Reid, K.B., Ghebrehiwet, B., Peerschke, E.I., Leigh, L.A., and Preissner, K.T. (1996). The binding protein for globular heads of complement C1q, gC1qR. Functional expression and characterization as a novel vitronectin binding factor. J. Biol. Chem. 271, 26739-26744.
28. Liu, Y., Sainz, I.M., Wu, Y., Pixley, R., Espinola, R.G., Hassan, S., Khan, M.M., and Colman, R.W. (2008). The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases. Exp. Cell Res. 314, 774-788.
29. Magzoub, M. and Graslund, A. (2004). Cell-penetrating peptides: wcorrectedx from inception to application. Q. Rev. Biophys. 37, 147-195. (Erratum published in Q. Rev. Biophys. 37, 315.)
30. Mahdi, F., Shariat-Madar, Z., Kuo, A., Carinato, M., Cines, D.B., and Schmaier, A.H. (2004). Mapping the interaction between high molecular mass kininogen and the urokinase plasminogen activator receptor. J. Biol. Chem. 279, 16621-16628.
31. Mohamed, M.M. and Sloane, B.F. (2006). Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6, 764-775.
32. Moreira, C.R., Schmaier, A.H., Mahdi, F., da Motta, G., Nader, H.B., and Shariat-Madar, Z. (2002). Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator. FEBS Lett. 523, 167-170.
33. Moreira, C.R., Porcionatto, M.A., Dietrich, C.P., and Nader, H.B. (2003). Effect of BK and PMA on the synthesis of proteoglycans during the cell cycle of endothelial cells in culture. Int. Immunopharmacol. 3, 293-298.
34. Motta, G., Rojkjaer, R., Hasan, A.A.K., Cines, D.B., and Schmaier, A.H. (1998). High molecular weight kininogen regulates prekallikrein assembly and activation on endothelial cells: a novel mechanism for contact activation. Blood 91, 516-528.
35. Motta, G., Shariat-Madar, Z., Mahdi, F., Sampaio, C.A.M., and Schmaier, A.H. (2001). Assembly of HK and activation of prekallikrein on cell matrix. Thromb. Hemost. 86, 840-847.
36. Nader, H.B., Chavante, S.F., Dos-Santos, E.A., Oliveira, T.W., DePaiva, J.F., Jeronimo, S.M., Medeiros, G.F., De-Abreu, L.R., Leite, E.L., De-Sousa-Filho, J.F., et al. (1999). Heparan sulfates and heparins: similar compounds performing the same functions in vertebrates and invertebrates? Braz. J. Med. Biol. Res. 32, 529-538.
37. Nascimento, F.D., Hayashi, M.A., Kerkis, A., Oliveira, V., Oliveira, E.B., Rädis-Baptista, G., Nader, H.B., Yamane, T., dos Santos Tersariol, I.L., and Kerkis, I. (2007). Crotamine mediates gene delivery into cells through the binding to heparan sulfate proteoglycans. J. Biol. Chem. 282, 21349-21360.
38. Oliva, M.L., Grisolia, D., Sampaio, M.U., and Sampaio, C.A.M. (1982). Properties of highly purified human plasma kallikrein. Agents Actions (Suppl.) 9, 52-57.
39. Petrovic, N., Schacke, W., Gahagan, J.R., O'Conor, C.A., Winnicka, B., Conway, R.E., Mina-Osorio, P., and Shapiro, L.H. (2007). CD13/APN regulates endothelial invasion and filopodia formation. Blood 110, 142-150.
40. Puzer, L., Vercesi, J., Alves, M.F., Barros, N.M., Araujo, M.S., Juliano, M.A., Reis, M.L., Juliano, L., and Carmona, A.K. (2005). A possible alternative mechanism of kinin generation in vivo by cathepsin L. Biol. Chem. 386, 699-704.
41. Renné, T. and Müller-Esterl, W. (2001). Cell surface-associated chondroitin sulfate proteoglycans bind contact phase factor H-kininogen. FEBS Lett. 500, 36-40.
42. Renné, T., Dedio, J., David, G., and Müller-Esterl, W. (2000). High molecular weight kininogen utilizes heparan sulfate proteoglycans for accumulation on endothelial cells. J. Biol. Chem. 275, 33688-33696.
43. Renné, T., Schuh, K., and Müller-Esterl, W. (2005). Local BK formation is controlled by glycosaminoglycans. J. Immunol. 175, 3377-3385.
44. Schmaier, A.H. (2000). Plasma kallikrein/kinin system: a revised hypothesis for its activation and its physiologic contributions. Curr. Opin. Hematol. 7, 261-265.
45. Schmaier, A.H., Wahl, R., Fisher, S.J., and Brenner, D. (1998). The pharmacokinetics of the kininogens. Thromb. Res. 92, 293-297.
46. Schousboe, I., Thomsen, P., and van Deurs, B. (2004). Factor XII binding to endothelial cells depends on caveolae. Eur. J. Biochem. 271, 2998-3005.
47. Segel, I.H. (1975). Enzyme Kinetics: Behaviour and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems (New York, USA: John Wiley & Sons), pp. 452-464.
48. Shariat-Madar, Z., Mahdi, F., and Schmaier, A.H. (2002). Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. J. Biol. Chem. 277, 17962-17969.
49. Shimamoto, K., Ando, T., Nakao, T., Tanaka, S., Sakuma, M., and Miyahara, M. (1978). A sensitive radioimmunoassay for urinary kinins in man. J. Lab. Clin. Med. 91, 721-728.
50. Turk, V., Turk, B., Guncar, G., Turk, D., and Kos, J. (2002). Lysosomal cathepsins: structure, role in antigen processing and presentation, and cancer. Adv. Enzyme Regul. 42, 285-303.
51. van Iwaarden, F., de Groot, P.G., Sixma, J.J., Berrettini, M., and Bouma, B.N. (1988). High-molecular weight kininogen is present in cultured human endothelial cells: localization, isolation, and characterization. Blood 71, 1268-1276.
52. Wu, Y., Rizzo, V., Liu, Y., Sainz, I.M., Schmuckler, N.G., and Colman, R.W. (2007). Kininostatin associates with membrane rafts and inhibits αvβ3 integrin activation in human umbilical vein endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, 1968-1975.
53. Zhao, Y., Qiu, Q., Mahdi, F., Shariat-Madar, Z., Røjkjaer, R., and Schmaier, A.H. (2001). Assembly and activation of HK-PK complex on endothelial cells results in BK liberation and NO formation. Am. J. Physiol. Heart Circ. Physiol. 280, H1821-H1829.